Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®

NCT01591902 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

129

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Retinopathy
HIV

Interventions

DRUG: Tesamorelin
DRUG: Placebo-Control

Sponsor

Theratechnologies